Diazyme Laboratories, Inc.
Records under this name other than the patents Diazyme Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to Diazyme Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,476,034 | Methods and compositions for assaying homocysteine Term ended Term ended Apr 2, 2026 · From the USPTO record | Term ended | Term ended Apr 2, 2026 | From the USPTO record |
| US 8,460,880 | Compositions, splice variants and methods relating to ovarian specific genes and proteins Term ended Term ended Jun 16, 2025 · High confidence | Term ended | Term ended Jun 16, 2025 | High confidence |
| US 8,444,971 | OVR110 antibody compositions and methods of use Lapsed on the fee record Ended May 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 21, 2025 | From the USPTO record |
| US 7,619,068 | Ovr110 antibody compositions and methods of use Term ended Term ended May 10, 2024 · From the USPTO record | Term ended | Term ended May 10, 2024 | From the USPTO record |
| US 7,097,968 | Methods and compositions for assaying homocysteine Term ended Term ended Mar 15, 2024 · From the USPTO record | Term ended | Term ended Mar 15, 2024 | From the USPTO record |
| US 7,153,666 | Methods and compositions for determination of glycated proteins Term ended Term ended Dec 9, 2023 · From the USPTO record | Term ended | Term ended Dec 9, 2023 | From the USPTO record |
| US 8,906,369 | Ovr110 antibody compositions and methods of use Lapsed on the fee record Ended Dec 9, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2022 | From the USPTO record |
| US 8,354,508 | PRO115 Antibody Compositions and Methods of Use Lapsed on the fee record Ended Jan 15, 2021 · High confidence | Lapsed on the fee record | Ended Jan 15, 2021 | High confidence |
| US 8,318,501 | Methods for assaying percentage of glycated hemoglobin Lapsed on the fee record Ended Nov 27, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2020 | From the USPTO record |
| US 8,287,867 | Ovr115 antibody compositions and methods of use Lapsed on the fee record Ended Oct 16, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2020 | From the USPTO record |